Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Michael Sela
01.05.2009
From student to Institute Vice President
10.10.2007
Israeli scientists identify: Genes that Affect Responses of Multiple Sclerosis Patients to Copaxone®
...
14.09.2007
Prof. Michael Sela received the National Italian Decoration of the Italian Solidarity Star (O.S.S.I.) conferred by the President of the Italian...
01.04.2005
Right combination of customized antibodies may destroy cancer cell's communication network
...
01.09.2004
Space & Physics, Biochemistry, Brain & Behavior, Cancer, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Genetics, Structural Biology
Even after a malignant transformation has occurred, the budding tumor is a microscopic lump that doesn’t do much harm until...
01.03.2001
Basic research and its practical applications
by Prof. Michael Sela
Excerpts from...
01.05.2000
Leading research institute heads join in the Jubilee celebrations at the Institute
01.05.1997
Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS
13.04.1997
Weizmann Institute's Prof. Michael Sela First Israeli Winner of Interbrew-Baillet Latour Health Prize
...23.12.1996
REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli...
